A Simple Strategy to Reduce Contrast Media Use and Risk of Contrast-Induced Renal Injury during PCI: Introduction of an “Optimal Contrast Volume Protocol” to Daily Clinical Practice
暂无分享,去创建一个
G. Ziubryte | G. Jaruševičius | R. Unikas | A. Žebrauskaitė | Austeja Lieponyte | Austeja Lieponyte | Aiste Zebrauskaite | Greta Ziubryte | Lukas Mackus | Evelina Kairyte | Ramunas Unikas | Gediminas Jarusevicius | Aiste Zebrauskaite | Lukas Mackus | Evelina Kairyte
[1] S. Campo,et al. Acute Kidney Injury and Sepsis after Cardiac Surgery: The Roles of Tissue Inhibitor Metalloproteinase-2, Insulin-like Growth Factor Binding Protein-7, and Mid-Regional Pro-Adrenomedullin , 2023, Journal of clinical medicine.
[2] Edward G. Clark,et al. Canadian Association of Radiologists Guidance on Contrast Associated Acute Kidney Injury , 2022, Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes.
[3] N. Irrera,et al. Optimizing the Outcomes of Percutaneous Coronary Intervention in Patients with Chronic Kidney Disease , 2022, Journal of clinical medicine.
[4] F. Wilson,et al. AACC Guidance Document on Laboratory Investigation of Acute Kidney Injury. , 2021, The journal of applied laboratory medicine.
[5] J. Gore,et al. ACR Appropriateness Criteria® Renal Failure. , 2021, Journal of the American College of Radiology : JACR.
[6] A. Colombo,et al. Ultra-Low Contrast Percutaneous Coronary Intervention to Minimize the Risk for Contrast-Induced Acute Kidney Injury in Patients With Severe Chronic Kidney Disease. , 2019, The Journal of invasive cardiology.
[7] H. Gurm,et al. Contemporary use of and outcomes associated with ultra‐low contrast volume in patients undergoing percutaneous coronary interventions , 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[8] A. Colombo,et al. Incidence of contrast-induced acute kidney injury in a large cohort of all-comers undergoing percutaneous coronary intervention: Comparison of five contrast media. , 2018, International journal of cardiology.
[9] S. Fakhran,et al. Contrast-Induced Acute Kidney Injury: Pathophysiology, Manifestations, Prevention, and Management. , 2017, Magnetic resonance imaging clinics of North America.
[10] A. Kastrati,et al. Preventive Strategies for Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Procedures: Evidence From a Hierarchical Bayesian Network Meta-Analysis of 124 Trials and 28 240 Patients , 2017, Circulation. Cardiovascular interventions.
[11] Mingyu Liang,et al. Antithrombin III Protects Against Contrast-Induced Nephropathy , 2017, EBioMedicine.
[12] N. Kafkas,et al. Neutrophil Gelatinase–Associated Lipocalin as an Early Marker of Contrast‐Induced Nephropathy After Elective Invasive Cardiac Procedures , 2016, Clinical cardiology.
[13] H. Ly,et al. Contrast-Induced Nephropathy: From Pathophysiology to Preventive Strategies. , 2016, The Canadian journal of cardiology.
[14] B. Eryonucu,et al. Is Kidney Injury Molecule 1 a Valuable Tool for the Early Diagnosis of Contrast-Induced Nephropathy? , 2015, Journal of Investigative Medicine.
[15] S. David,et al. Subclinical and clinical contrast-induced acute kidney injury: data from a novel blood marker for determining the risk of developing contrast-induced nephropathy (ENCINO), a prospective study , 2015, Renal failure.
[16] Y. Ikari,et al. Safety margin of minimized contrast volume during percutaneous coronary intervention in patients with chronic kidney disease , 2014, Cardiovascular Intervention and Therapeutics.
[17] A. Khwaja. KDIGO Clinical Practice Guidelines for Acute Kidney Injury , 2012, Nephron Clinical Practice.
[18] H. Gurm,et al. Renal function-based contrast dosing to define safe limits of radiographic contrast media in patients undergoing percutaneous coronary interventions. , 2011, Journal of the American College of Cardiology.
[19] Richard Solomon,et al. Contrast-induced acute kidney injury. , 2010, Circulation.
[20] G. Sangiorgi,et al. Mehran Contrast-Induced Nephropathy Risk Score Predicts Short- and Long-Term Clinical Outcomes in Patients With ST-Elevation–Myocardial Infarction , 2010, Circulation. Cardiovascular interventions.
[21] Jeremiah R. Brown,et al. Does Safe Dosing of Iodinated Contrast Prevent Contrast-Induced Acute Kidney Injury? , 2010, Circulation. Cardiovascular interventions.
[22] K. Eagle,et al. Temporal management patterns and outcomes of non-ST elevation acute coronary syndromes in patients with kidney dysfunction. , 2009, European heart journal.
[23] F. Veglia,et al. Contrast Volume During Primary Percutaneous Coronary Intervention and Subsequent Contrast-Induced Nephropathy and Mortality , 2009, Annals of Internal Medicine.
[24] Jeremiah R. Brown,et al. Serious renal dysfunction after percutaneous coronary interventions can be predicted. , 2008, American heart journal.
[25] W. Laskey,et al. Volume-to-creatinine clearance ratio: a pharmacokinetically based risk factor for prediction of early creatinine increase after percutaneous coronary intervention. , 2007, Journal of the American College of Cardiology.
[26] John A Kellum,et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury , 2007, Critical care.
[27] Charles Davidson,et al. Risk prediction of contrast-induced nephropathy. , 2006, The American journal of cardiology.
[28] Joseph V Bonventre,et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. , 2005, Journal of the American Society of Nephrology : JASN.
[29] G. Stone,et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. , 2004, Journal of the American College of Cardiology.
[30] B. McNeil,et al. "Renalism": inappropriately low rates of coronary angiography in elderly individuals with renal insufficiency. , 2004, Journal of the American Society of Nephrology : JASN.
[31] K. Harjai,et al. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. , 2004, The American journal of cardiology.
[32] R. Bersin,et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. , 2004, JAMA.
[33] A. Takeshita,et al. The incidence and risk factors of cholesterol embolization syndrome, a complication of cardiac catheterization: a prospective study , 2003 .
[34] K. Kent,et al. Percutaneous coronary intervention‐associated nephropathy foreshadows increased risk of late adverse events in patients with normal baseline serum creatinine , 2003, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[35] Rosario V. Freeman,et al. Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose. , 2002, The American journal of cardiology.
[36] Kirk N. Garratt,et al. Incidence and Prognostic Importance of Acute Renal Failure After Percutaneous Coronary Intervention , 2002, Circulation.
[37] G. Stone,et al. Impact of gender on the incidence and outcome of contrast-induced nephropathy after percutaneous coronary intervention. , 2002, The Journal of invasive cardiology.
[38] S. Marsch,et al. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. , 2002, Archives of internal medicine.
[39] G. Dangas,et al. Acute renal failure requiring dialysis after percutaneous coronary interventions , 2001, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[40] G. Dangas,et al. The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. , 2000, Journal of the American College of Cardiology.
[41] W. O’Neill,et al. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. , 1997, The American journal of medicine.
[42] L. Hillis,et al. Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. , 1989, The American journal of medicine.
[43] M. H. Gault,et al. Prediction of creatinine clearance from serum creatinine. , 1975, Nephron.
[44] Michael E Matheny,et al. Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry. , 2014, JACC. Cardiovascular interventions.
[45] A. Jeremias,et al. Impact of Severity of Renal Dysfunction on Determinants of In-Hospital Mortality Among Patients Undergoing Percutaneous Coronary Intervention , 2012 .
[46] A. Budaj,et al. Reperfusion in patients with renal dysfunction after presentation with ST-segment elevation or left bundle branch block: GRACE (Global Registry of Acute Coronary Events). , 2009, JACC. Cardiovascular interventions.
[47] E. Halpern,et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study. , 1995, Kidney international.